PSB-603

CAS : 1092351-10-4

Ref. 3D-STB35110

Informations sur le produit

• Nom: PSB-603
• CAS: 1092351-10-4

Description

PSB-603 is a small molecule that inhibits the P2Y receptors, which are involved in signal transduction pathways. It has been shown to induce neuronal death by inhibiting the activation of Epidermal Growth Factor Receptor (EGFR) and downstream signaling pathways. PSB-603 has also been shown to have anticancer activity in prostate cancer cells, as well as other types of cancer cells. PSB-603 inhibits proliferation and induces apoptosis in prostate cancer cells through inhibition of EGFR and cAMP levels. The mechanism of action for this drug is not fully understood, but it is thought that it may block transcription or translation processes.

PSB-603 has also been studied for its potential therapeutic applications in autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and multiple sclerosis. This drug may be used to prevent cartilage degradation by blocking the production of inflammatory cytokines such as TNF-α, IL-1β

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 529.01 g/mol
• Formule: C₂₄H₂₅ClN₆O₄S
• Degré de pureté: Min. 95%